# A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People

> **NCT06367426** · PHASE1 · UNKNOWN · sponsor: **Pharmacobio** · enrollment: 100 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** DDN-A-0101 (SAD)
- **DRUG:** DDN-A-0101 (MAD)
- **DRUG:** Placebo (SAD)
- **DRUG:** Placebo (MAD)

## Key facts

- **NCT ID:** NCT06367426
- **Lead sponsor:** Pharmacobio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06367426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06367426, "A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06367426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*